Navigation Links
Caliper CEO Kevin Hrusovsky Presented Vision for Revolutionizing Medicine
Date:11/7/2011

HOPKINTON, Mass., Nov. 7, 2011 /PRNewswire/ -- Caliper Life Sciences, Inc. (NASDAQ: CALP), a leading provider of tools and services for life science companies, today announced that Kevin Hrusovsky, President and CEO of Caliper delivered a keynote address at the BioConference Live event, which was held on October 26, and participated in the Personalized Medicine Panel during the World Health Forum on October 27 held at Harvard Medical School.

The keynote titled, "A Revolution in Personalized Medicine - from Concept to Reality," highlighted the "sick" state of our current healthcare system, given the high cost of care and the lack of effective result for the patient.  The keynote described what aspects of medical innovation are working and where excess treatment may actually be harmful to the patient. For example, on average only 25 percent of oncology therapeutic treatments are effective, and all patients are potentially harmed by the side effects of disease treatment. This forward looking presentation provided a view to the tools and techniques that will transform healthcare, focusing on innovative technologies in areas like genomic analysis, biomarkers, and imaging that will improve the ability to detect disease at earlier levels and determine the appropriate individualized treatments necessary to ensure the most beneficial patient outcome.  Hrusovsky also described advancements in biotherapeutics, targeted small molecules, and regenerative medicine that will provide physicians with better treatment options for their patients.

"Despite the trillions of dollars spent on medical research, a child born today has a shorter life expectancy than his or her parent," said Kevin Hrusovsky, President and CEO of Caliper Life Sciences. "The practice of medicine today is reactionary and more appropriately described as 'sick care' instead of 'health care.' At Caliper, we are committed to developing and commercializing disruptive technologies that improve the quality and length of life for all humankind, creating a revolution in healthcare that enables individualized treatment in a way that is economically sustainable."

A replay of the BioConference Live keynote presentation is available at http://www.bioconferencelive.com/events.php?event_id=1&layout=speakers

About Caliper Life Sciences

Caliper is a premier provider of cutting-edge technologies enabling researchers in the life sciences industry to create life-saving and enhancing medicines and diagnostic tests more quickly and efficiently. Caliper is aggressively innovating new technology to bridge the gap between in vitro assays and in vivo results, enabling researchers to translate those results into cures for human disease. Caliper's portfolio of offerings includes state-of-the-art microfluidics, lab automation & liquid handling, tissue microscopy, preclinical imaging technologies, and discovery & development outsourcing solutions. For more information please visit www.caliperLS.com.


'/>"/>
SOURCE Caliper Life Sciences, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Caliper Life Sciences Introduces Drug Combination Services to Identify Synergistic Response of Compounds
2. Caliper Life Sciences Optical Imaging Technology Selected to Aid Tuberculosis Research Efforts by the Texas A&M Health Science Center
3. Caliper Life Sciences Presents LabChip(R) Platform to the U.S. Food and Drug Administration
4. Caliper Awarded New Task Order for EPA ToxCast Program
5. Caliper Life Sciences Introduces Sciclone(R) G3 Liquid Handler
6. Caliper Life Sciences Partners with Prestwick Chemical to Offer Customized Chemistry and Biology Programs for Drug Discovery Research
7. Caliper Completes Strategic Sale of Small Animal Services Subsidiary to Taconic
8. Caliper Life Sciences Forms Scientific Advisory Board for Next Generation Sequencing
9. Caliper Life Sciences Fourth Quarter 2009 Financial Results Conference Call Notice
10. Caliper Life Sciences and Stanford University File a Patent Infringement Lawsuit Against Carestream Health, Inc.
11. Caliper Settles Outstanding Litigation with Shimadzu
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/7/2017)... Ind. , Sept. 7, 2017  Zimmer Biomet ... in musculoskeletal healthcare, today announced that it will be ... Global Healthcare Conference at the Grand Hyatt hotel in ... 11, 2017 at 11:40 a.m. Eastern Time. ... via Zimmer Biomet,s Investor Relations website at http://investor.zimmerbiomet.com ...
(Date:9/6/2017)... Sept. 6, 2017 NeuroRx, a clinical stage biopharma ... and Behavior (ASIB), has been granted Fast Track status by ... of NRX-100 (ketamine HCl) followed by NRX-101 (D-cycloserine + lurasidone). ... trial of this sequential therapy targeting patients who are admitted ... ...
(Date:9/5/2017)... LONDON , Sept. 5, 2017  Just 18 ... Valid Insight is pleased to announce the appointment of ... Tammy Wynne , Dominic Jones-Phillips and ... from industry. ... a team of market access writers. She has over ...
Breaking Medicine Technology:
(Date:9/21/2017)... ... September 21, 2017 , ... Japanese Zen artist couple, Fumie ... on 6th, 7th and 8th October at Miranda Kuo Gallery on Lower East Side, ... such as Zen Kodo mat. Wanderlust , one of the largest US yoga ...
(Date:9/21/2017)... (PRWEB) , ... September 21, 2017 , ... ... of the Month, Lewis and Clark College Emeritus Professor of Education Gregory A. ... Boninger, co-author of Asleep at the Switch: Schoolhouse Commercialism, Privacy, and the ...
(Date:9/20/2017)... (PRWEB) , ... September 20, 2017 , ... ... of providing a voice for people who have kidney disease. The theme “Describe ... to share their stories. Entrants needed to meet only one qualification— to ...
(Date:9/20/2017)... (PRWEB) , ... September 20, 2017 , ... ... the Orthodontics and Clear Aligner clinical and commercial support services market) has entered ... Dentistry (PGSD) in Sydney, Australia. , The PGSD is the first private ...
(Date:9/20/2017)... ... September 20, 2017 , ... ... social campaign, “Humans With Vaginas.” The goal is to ignite conversation via social ... personal care products. The brand has declared September “Humans with Vaginas” month, releasing ...
Breaking Medicine News(10 mins):